Quantitation of Glymphatic Functioning in Sleep and Meditative States
NCT ID: NCT04506892
Last Updated: 2025-08-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
75 participants
INTERVENTIONAL
2021-02-01
2024-12-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
MRI Neurofeedback and Brain Circuits Related to Motivation in Healthy Participants
NCT05929898
MRI Measurement of Brain Metabolism Across the Sleep-Wake Cycle
NCT00117221
Brain Imaging Technology to Examine the Effects of Meditation
NCT00082160
Glymphatic MRI Study
NCT06452459
Functional Neuroanatomy of Emotion Perception, Recognition, Learning, and Memory
NCT00458432
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adept Meditators
Subjects will undergo scanning during awake, sleep deprived, and meditative states of consciousness.
Meditation
meditation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Meditation
meditation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* "Adept meditator status"
Exclusion Criteria
* Claustrophobia or inability to lie still for prolonged periods of time
* Participants with a recent (less than 2 months) infection, tattoo, or wound
* No consumption of stimulants or alcohol within 12 hours of the study visit
* clinical diagnosis of any major neurological or psychological condition
* Taking benzodiazepines, cholinestorase inhibitors, anti-psychotics, opioids, MAO inhibitors
18 Years
45 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vanderbilt University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Daniel Claassen
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Daniel Claassen, MD
Role: PRINCIPAL_INVESTIGATOR
Vanderbilt University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vanderbilt University Medical Center
Nashville, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RFA-AT-21-001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.